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Chronic inflammatory arthritis, a hall-
mark of several inflammatory rheumatic
diseases, and inflammatory bowel disease
are both life-long conditions, with sub-
stantial morbidity and even mortality.
These diseases are highly prevalent—for
example, chronic arthritis has a frequency
of approximately 2%–3% within a given
population. Interestingly, the co-existence
of gut and joint inflammation was found to
be prominent in spondyloarthritis (SpA), a
family of interrelated rheumatologic dis-
eases. SpA has a number of typical clinical
and genetic characteristics, including pe-
ripheral arthritis (particularly of lower
limb joints) as well as inflammation of
the axial skeleton (e.g., spine). Moreover,
different forms of SpA may also affect
other organs, such as the skin (psoriasis) or
the eye (anterior uveitis), demonstrating
the systemic nature of these diseases.
Various subtypes of SpA have been
described based upon clinical features,
but any two may share important charac-
teristics. The prototypical disorder of the
SpA family is ankylosing spondylitis (AS),
which is characterized by prominent
inflammation of the axial skeleton (spine,
sacroiliac joints), although other joints may
also be affected. Other SpA diseases
include infection-triggered reactive arthri-
tis, some forms of juvenile idiopathic
arthritis, arthritis in association with in-
flammatory bowel diseases (IBD), and
some forms of psoriatic arthritis [1,2].
The striking relationship between IBD
and AS has been recognized for many years:
up to 10% of IBD patients develop AS, and,
vice versa, IBD commonly develops in
patients primarily diagnosed with AS [3].
As both have an important underlying
genetic heritability, it has been suggested
that the two diseases could have an
overlapping set of predisposing genes.
Strong evidence for this idea has been
derived from the Icelandic genealogy data-
base: it was shown that AS and IBD have a
strong elevated cross-risk ratio in first- and
second-degree relatives. However, the pre-
cise nature of the predisposing genes
remained unknown for some time [4].
In this issue of PLoS Genetics, Danoy
et al. [5] report on the results of genome-
wide association studies looking at a set of
recently identified Crohn’s disease (CD)
susceptibility genes in a large cohort of AS
patients [6]. This is the first large-scale
study to address the issue of a possible
genetic link between CD and AS by using
a step-wise approach that includes both an
initial exploratory and a confirmatory
cohort. New loci associations were identi-
fied, including one within the intergenic
region at chr1q32, found near the gene
KIF21B, which encodes a protein of the
kinesin motor family involved in transport
along axonal and dendritic microtubules.
However, a clear-cut association with
KIR21B itself is not apparent from this
study, so undoubtedly more work is
needed in this area.
One particularly interesting aspect of
the paper is the elucidation of a strong
association with genes implicated in the
Th17 pathway, a lymphocyte subset that
has gathered much attention lately be-
cause of its prominent role in a variety of
immune-mediated inflammatory disor-
ders, including psoriasis and CD. While
the association of AS with the receptor for
IL-23, which is implicated in the expan-
sion and survival of Th17 cells, has been
previously reported [7,8], Danoy and co-
workers provide two additional links to the
Th17 pathway. Firstly, they report a clear
association with STAT-3, which is,
amongst other things, implicated in IL-
23R signal transduction. In addition, an
association with the p40 subunit shared
between IL-12 and IL-23 was revealed. It
is intriguing that so many genes predispose
to AS. The functional significance of these
associations is, however, presently unclear.
For example, some of the IL-23R single
nucleotide polymorphisms associated with
AS may confer either protection or
susceptibility to the disease [7]. Neverthe-
less, more than 30 years after the discovery
of HLA-B27 as a strong hereditability
factor for AS [9], further evidence points
to an important genetic susceptibility for
adaptive immunity shared with CD [10].
Danoy et al. also found significant but
weaker associations with the LRR2/
MUC19 locus. This locus contains genes
involved in the process of autophagy and
epithelial integrity, respectively.
However, one important limitation of
the new study is the potential bias caused
by subclinical bowel inflammation. Ap-
proximately two-thirds of patients suffer-
ing from SpA, including AS, have micro-
scopic signs of gut inflammation without
any accompanying clinical gastrointestinal
symptoms [11–13]. In fact, mucosal alter-
ations are one of the first signs of ongoing
inflammation in SpA. Histologically, the
gut inflammation can be divided into
acute (mimicking a short-term and self-
limiting bacterial enterocolitis) and chron-
ic types (with altered intestinal architec-
ture, blunted and fused villi, and influx by
mononuclear cells), common in entero-
genic-triggered reactive arthritis and AS
patients, respectively [12]. Furthermore,
6%–13% of these patients eventually
develop IBD, particularly CD. This pro-
gression to overt CD is a very peculiar
feature of the chronic type of inflamma-
tion where up to 20% of those that have
chronic gut inflammation develop CD
[3,14]. Thus, even though the results of
the present study were not altered signif-
icantly by excluding the cases of clinical
IBD, it is conceivable that the genetic
overlap between IBD and AS may be
mirrored by the presence of subclinical gut
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for the chronic type of inflammation.
Previously, a similar genetic link to the
chronic subtype of inflammation was
found for CARD15 [15], single nucleotide
polymorphisms of which are also strongly
linked to CD [16–18]. However, the
frequency of CARD15 variants was not
elevated in SpA patients with an acute
type of inflammation or in patients lacking
signs of mucosal inflammation [15]. Thus,
it is clear that more studies are needed
linking the presence of subclinical gut
inflammation in AS to the association of
genes. Other items on the research agenda
should include the functional significance
of the identified gene polymorphisms in
shaping the immune response and the
potential interaction between the single
nucleotide polymorphism of the various
genes identified and their impact on
clinical manifestation of disease. It is clear
that exciting times lie ahead for this area of
research.
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